BriefCam’s edge analytics initiative will complement its portfolio of on-premise and cloud solutions, by enabling greater freedom of choice for flexible deployment architectures through edge-based computing, with a targeted availability for H1 2021. Read more...
Read MoreInfluitive works with forward-thinking marketers and digital businesses who want a better way to engage customers and mobilize advocates to increase referrals, references, reviews, case studies, and more. Our easy-to-use SaaS platform combines industry-leading customer advocacy tools, expert services, and training with intelligent automation, gamification, and personalization features that drive extreme engagement and customer growth at scale. Read...
Read MoreAs a solo entrepreneur you need to the right resources to help you stay connected and the most productive. Thankfully there are a wide variety of tools available for business owners who want to transition themselves into becoming a coaching leader in their industry. Are you ready for some great tools to get started? Use these online resources, and let me know how these work for you! Read...
Read MoreSight Diagnostics, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, has raised $71 million in Series D funding with participation from Koch Disruptive Technologies, Longliv Ventures and OurCrowd. This new round brings Sight’s total funding to more than $124 million and will support the expansion of Sight’s commercial operations globally and advance Sight’s R&D into the detection of additional diseases as well as biomarkers indicating COVID-19 severity. Read more...
Read MoreAs the race to find diagnostic technology for coronavirus continues, there is hope out of Israel where a startup is behind the first FDA-cleared fingerstick Complete Blood Count (CBC) analyzer. The blood samples from the fingerstick reveal critical information within minutes, giving doctors the ability to provide treatment on the spot at the point of care. FOX’s Trey Yingst speaks with Eli Groner, the managing director of Koch Disruptive Technology and Yossi Pollak, CEO and co-founder of Sight Diagnostics, on the benefits of this technology for patients, doctors and insurers alike....
Read More
